West Pharmaceutical Services, EPS diluito del terzo trimestre 2026 sale del 57% a 3,02 dollari
West Pharmaceutical Services, EPS diluito del terzo trimestre 2026 sale del 57% a 3,02 dollari W
Related stories
TAIEX Hits Over 2-Month Low, Suffers Monthly Loss
The TAIEX, Taiwan’s benchmark stock index, slumped 1,157 points, or 2.5%, to close at 45,212 on Friday, extending losses from the previous session and tracking a sharp fall in US s
H impact | EARNINGS | Oct 30, 2026, 06:22 AM UTC
Global Dominion Raises Profit 35% in First Nine Months
Global Dominion reported a 35% increase in profit for the first nine months.
M impact | EARNINGS | Oct 30, 2026, 06:20 AM UTC
SCOR Q3 Net Income Falls as Catastrophe Losses Rise
France-based reinsurer SCOR reported lower Q3 net income as catastrophe losses rose.
M impact | EARNINGS | Oct 30, 2026, 06:12 AM UTC
Toyota Industries H1 Profit Surges on Higher Revenues
Toyota Industries reported that first-half profit attributable to owners of the parent nearly doubled, alongside strong revenue growth.
H impact | EARNINGS | Oct 30, 2026, 06:04 AM UTC
DHI FY2026 profit falls 19.41%
DHI reported FY2026 profit attributable to shareholders of 28.89亿美元, down 19.41% year over year. Basic EPS was 10.14美元.
M impact | EARNINGS | Oct 30, 2026, 05:41 AM UTC
Starbucks sees higher profit ahead amid turnaround progress
Starbucks expects higher profit, citing progress in its turnaround.
M impact | EARNINGS | Oct 30, 2026, 05:25 AM UTC